Education
About Us
Working with TipRanks
Follow Us
DarioHealth Corp (DRIO)
NASDAQ:DRIO
DRIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.50 - $1.91
Previous CloseN/A
Volume780.96K
Average Volume (3M)257.39K
Market Cap
$29.01M
Enterprise Value$59.34M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$30.34M
Price to Earnings (P/E)―
Beta1.66
Next Earnings
Aug 18, 2025EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding43,949,425
10 Day Avg. Volume206,931
30 Day Avg. Volume257,387
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.36
Price to Sales (P/S)0.00
P/FCF Ratio-0.90
Enterprise Value/Market Cap2.05
Enterprise Value/Revenue0.61
Enterprise Value/Gross Profit4.03
Enterprise Value/Ebitda-0.29
Forecast
1Y Price Target
$1.25Price Target Upside89.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
DarioHealth News
PremiumCompany Announcements
DarioHealth’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
DarioHealth Reports Increased Revenue Amid Rising Losses
PremiumCompany Announcements
DarioHealth Secures New Credit Agreement with Lenders
PremiumCompany Announcements
DarioHealth Announces CFO Resignation and Successor---
Bulls Say, Bears Say
Bulls Say
Financial Performance4Q revenue of $7.6M beat our estimate of $7.3M, driven by B2B revenue of $5.7M coming in ahead of our $5.4M estimate.
Growth ProspectsDRIO expects to see its client count of 83 to grow 50% throughout 2025.
New Contracts And PartnershipsManagement signed a major national health plan and regional health plan, expected to launch soon.
Bears Say
Demand EnvironmentThe demand environment for digital health has remained challenged, contributing to several consecutive quarters of revenues coming in below estimates.
Revenue ChallengesRevenue missed estimates driven by weakness in the B2B2C segment.
Strategic PartnershipsThere is limited visibility on DRIO's strategic partnerships channel, which is on track to generate zero revenues in 2024.
---
Ownership Overview
7.01% Insiders
1.40% Mutual Funds
13.19% Other Institutional Investors
77.47% Public Companies and
Individual Investors
DRIO FAQ
What was DarioHealth Corp’s price range in the past 12 months?
DarioHealth Corp lowest stock price was $0.50 and its highest was $1.91 in the past 12 months.
What is DarioHealth Corp’s market cap?
DarioHealth Corp’s market cap is $29.01M.
When is DarioHealth Corp’s upcoming earnings report date?
DarioHealth Corp’s upcoming earnings report date is Aug 18, 2025 which is in 91 days.
How were DarioHealth Corp’s earnings last quarter?
DarioHealth Corp released its earnings results on May 14, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.04.
Is DarioHealth Corp overvalued?
According to Wall Street analysts DarioHealth Corp’s price is currently Undervalued.
Does DarioHealth Corp pay dividends?
DarioHealth Corp does not currently pay dividends.
What is DarioHealth Corp’s EPS estimate?
DarioHealth Corp’s EPS estimate is -0.2.
How many shares outstanding does DarioHealth Corp have?
DarioHealth Corp has 43,949,425 shares outstanding.
What happened to DarioHealth Corp’s price movement after its last earnings report?
DarioHealth Corp reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of DarioHealth Corp?
Currently, no hedge funds are holding shares in DRIO
---
DarioHealth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.25 (89.39% Upside)
$1.25 (89.39% Upside)
Blogger Sentiment
Bullish
DRIO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 313.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $4.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 2.3%
Last 30 Days ▲ 2.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.89%
12-Months-Change
Fundamentals
Return on Equity
-42.58%
Trailing 12-Months
Asset Growth
-15.60%
Trailing 12-Months
Company Description
DarioHealth Corp
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
---
DRIO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
DarioHealth reported strong client acquisition and improvements in gross margins and operating expenses. However, the quarter faced challenges with sequential revenue decline and large client contract transitions. Despite these challenges, the company remains optimistic about future growth through strategic partnerships and AI-driven efficiencies.Read More>---
DRIO Stock 12 Month Forecast
Average Price Target
$1.25
▲(89.39% Upside)
Technical Analysis
Tenax Therapeutics
―
Pulmatrix
―
VYNE Therapeutics
―
Cognition Therapeutics
―
CytoMed Therapeutics Limited
―
---